Nantahala-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
133
Total Value
2187261798
Accession Number
0001104659-25-049574
Form Type
13F-HR
Manager Name
Nantahala-Capital-Management
Data Enrichment
90% identified
120 identified13 unidentified

Holdings

133 positions • $2.2B total value
Manager:
Search and click to pin securities to the top
Page 5 of 7
GAIA, INC
Shares:914.6K
Value:$3.5M
% of Portfolio:0.2% ($3.5M/$2.2B)
88338H704
Shares:2.4M
Value:$3.5M
% of Portfolio:0.2% ($3.5M/$2.2B)
COLUMBUS MCKINNON CORP
Shares:200.0K
Value:$3.4M
% of Portfolio:0.2% ($3.4M/$2.2B)
DHI GROUP, INC.
Shares:2.4M
Value:$3.3M
% of Portfolio:0.2% ($3.3M/$2.2B)
Shares:1.4M
Value:$3.3M
% of Portfolio:0.1% ($3.3M/$2.2B)
EyePoint Pharmaceuticals, Inc.
Shares:593.1K
Value:$3.2M
% of Portfolio:0.1% ($3.2M/$2.2B)
67577R102
Shares:3.2M
Value:$3.1M
% of Portfolio:0.1% ($3.1M/$2.2B)
Scully Royalty Ltd.
Shares:368.2K
Value:$3.0M
% of Portfolio:0.1% ($3.0M/$2.2B)
Senti Biosciences, Inc.
Shares:888.0K
Value:$3.0M
% of Portfolio:0.1% ($3.0M/$2.2B)
Silence Therapeutics plc
Shares:1.0M
Value:$2.9M
% of Portfolio:0.1% ($2.9M/$2.2B)
00439U104
Shares:1.2M
Value:$2.7M
% of Portfolio:0.1% ($2.7M/$2.2B)
Surrozen, Inc./DE
Shares:229.5K
Value:$2.7M
% of Portfolio:0.1% ($2.7M/$2.2B)
READING INTERNATIONAL INC
Shares:1.9M
Value:$2.7M
% of Portfolio:0.1% ($2.7M/$2.2B)
scPharmaceuticals Inc.
Shares:995.4K
Value:$2.6M
% of Portfolio:0.1% ($2.6M/$2.2B)
Structure Therapeutics Inc.
Shares:150.0K
Value:$2.6M
% of Portfolio:0.1% ($2.6M/$2.2B)
Keros Therapeutics, Inc.
Shares:250.0K
Value:$2.5M
% of Portfolio:0.1% ($2.5M/$2.2B)
ABEONA THERAPEUTICS INC.
Shares:520.0K
Value:$2.5M
% of Portfolio:0.1% ($2.5M/$2.2B)
ACHIEVE LIFE SCIENCES, INC.
Shares:898.9K
Value:$2.4M
% of Portfolio:0.1% ($2.4M/$2.2B)
OWENS & MINOR INC/VA/
Shares:200.0K
Value:$1.8M
% of Portfolio:0.1% ($1.8M/$2.2B)
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
Shares:2.5M
Value:$1.7M
% of Portfolio:0.1% ($1.7M/$2.2B)